Trial intelligence / Profile preview

Influenza vaccination timing during chemotherapy in breast and colorectal cancer patients

NL-OMON20352Not yet recruiting

Sponsor
University Medical Center of Southern Nevada
Start
Sep 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised, open-label trial of influenza vaccine in influenza (3 arms), sponsored by University Medical Center of Southern Nevada. Primary endpoint: Adequate rise in antibody titre. Planned start Sep 2011; status: not yet recruiting.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON20352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call